Daichi Yamasoba a, d, Yusuke Kosugi a, Izumi Kimura a, Shigeru Fujita a, Keiya Uriu a, Jumpei Ito a, Kei Sato a, b, c, e
for the Genotype to Phenotype Japan (G2P-Japan) Consortium
a Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan
b International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan
c International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan
d School of Medicine, Kobe University, Kobe, Hyogo, Japan
e CREST, Kawaguchi, Saitama, Japan